Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Dezember 2011 09:15 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience, Inc. Appoints Former Quigley Corporation COO, Charles A. Phillips, to the Board of Directors

SCHOFIELD, Wis., Dec. 12, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience Inc. (OTCBB:PMBS) is pleased to announce the appointment of Charles A. Phillips to the Board of Directors. Phillips began his...
06. Dezember 2011 09:15 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience Inc. Announces Initial Series of Purchase Orders for LipiGesic(R)M With 2nd Largest Drug Chain in the United States, CVS

SCHOFIELD, Wis., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience Inc. (OTCBB:PMBS) announced today that it has received an initial series of purchase orders for its new over-the-counter migraine...
28. November 2011 09:15 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience, Inc. Announces LipiGesic(TM) M Now Available at Walgreens

SCHOFIELD, Wis., Nov. 28, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that their new non-prescription migraine medication, LipiGesic™ M, is now available for...
20. September 2011 09:45 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience, Inc. Achieves National Distribution With One of the Top Retailers in the United States

SCHOFIELD, Wis., Sept. 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that they have received the initial series of purchase orders with one of the top retailers in...
15. August 2011 11:50 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience, Inc. Selects Media Relations, Inc. to Handle Launch of Its New Migraine Treatment, LipiGesic M

MINNEAPOLIS, Aug. 15, 2011 (GLOBE NEWSWIRE) -- PuraMed BioSciences, Inc. (OTCQB:PMBS) has chosen Media Relations, Inc. to create consumer awareness and excitement nationally for LipiGesic M, the...
20. Juli 2011 09:00 ET | Quelle: PuraMed BioScience, Inc.

Top-Tier Medical Journal Headache Publishes in Print the Clinical Study Results of PuraMed BioScience, Inc. Revolutionary New Migraine Medication LipiGesic(TM) M

SCHOFIELD, Wis., July 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M...
11. Juli 2011 09:00 ET | Quelle: PuraMed BioScience, Inc.

Independent Clinical Study of PuraMed BioScience's Non-Prescription Migraine Medication LipiGesic(TM) M to be Presented at 2011 Headache Update Conference

SCHOFIELD, Wis., July 11, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that leading headache researcher Dr. Roger Cady, MD will be exhibiting a poster presentation...
02. Juni 2011 12:22 ET | Quelle: PuraMed BioScience, Inc.

Video Release -- Top-Tier Medical Journal Headache Publishes Clinical Study Results of PuraMed BioScience, Inc. Revolutionary New Migraine Medication LipiGesic(TM) M

SCHOFIELD, Wis., June 2, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M...
14. April 2011 10:00 ET | Quelle: PuraMed BioScience, Inc.

PuraMed BioScience, Inc. Pursues Initial Contact With Top National Retail Outlets to Introduce Non-Prescription Migraine Medication LipiGesic(TM) M

SCHOFIELD, Wis., April 14, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is providing an update to its shareholders regarding the next steps in introducing its non-prescription...
06. April 2011 11:55 ET | Quelle: PuraMed BioScience, Inc.

Clinical Study of PuraMed BioScience, Inc. Product LipiGesic(TM) M Accepted for Publication in Top-Ranked Medical Journal

SCHOFIELD, Wis., April 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that the independent clinical study of LipiGesic™ M has been accepted for publication in...

Nächste Seite